New Research Finds Robust Expansion in Global Single-Use Bioreactors Market During 2017-2026 at a CAGR of 13.5%


Albany, NY — 12/29/2017 — Single-use bioreactor technology has now become an established addition to today's biotechnology manufacturing facility. In such facilities, single-use bioreactors are important commodities which provide flexibility in the production of multiple drugs. Also, by consuming minimum costs and time, single-use bioreactors can maintain the quality of drug production and eliminate the downtime caused by line clearance and cleaning validation. Recently, a study titled “Single-Use Bioreactors Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017-2026″ has been publicized to the online repository of Market Research Hub (MRH), which states that the key role of single-use bioreactors in boosting the production of pharmaceuticals is anticipated to drive their demand in the forthcoming years.

Request Free Sample Report:

Forecast Analysis

The research study provides a holistic perspective on market growth throughout the forecast period of 2017 to 2026 in terms of revenue estimates (in US$ Million) across different geographies, including Japan, North America, Asia-pacific excluding Japan, Latin America, MEA and Europe. Also, the report presents an in-depth analysis of the market dynamics including trends, drivers, challenges, opportunities, and regulatory framework of the global market.

In terms of geography, the research finds that, with nearly two-fifth revenue share, Europe is predicted to represent as the leading region in the global single-use bioreactors market in 2017. In addition, North America and the Asia-Pacific excluding Japan (APEJ) region are also anticipated to be at the forefront of global single-use bioreactor market expansion. Overall, during the forecast period of 2017-2026, the global market to become worth US$ 1.5 Bn by 2025, in terms of revenue, by expanding at a strong CAGR of 13.5% from 2017 to 2026.

Market Segmentation

For a better understanding of the market, the global market for single use bioreactors are broadly assessed on the basis of product type, end user, cells type, molecule type.

On the basis of product type, the market has been segmented into single use bioreactor systems, media bags, filtration assemblies, and others. The report projects that in 2017, the top-selling products in the global single-use bioreactors market will be observed to be single-use bioreactor systems and media bags. Collectively, these products will account for more than half of revenues procured in the global market.

Browse Full Report with TOC-

By cells type, the market is segmented into bacterial cells, yeast cells, mammalian cells, and other. By molecule type, the market is segmented into monoclonal antibodies (MABS), vaccines, stem cells, gene-modified cells and other molecules. It has been analyzed that mammalian cells are expected to witness the highest growth among others cell type. Moreover, there has also been a significant growth in the use of single-use bioreactors in the pharmaceutical industry across the globe. Research states that improvements in the bioreactor designs, film technology, sensor systems and magnificent mechanisms are ensuing in the increasing adoption of the single-use bioreactors.

Additionally, the vendor landscape section is also provided which throws light on the chief players dominant in this market. They are Distek, Sartorius Stedim Biotech, Applikon Biotechnology, Eppendorf, Merck Millipore, PBS Biotech, GE Healthcare, Solida Biotech, Danaher, Thermo Fisher Scientific, Parker Hannifin, Cesco Bioengineering, Cellexus, Celltainer Biotech and Pierre Guerin.

Enquire about this Report-

About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH's expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free : 800-998-4852 (US-Canada)
Email : [email protected]
Website :
Read Industry News at –

Powered by WPeMatico